Releaf
Mags Houston is an accomplished marketing professional with extensive experience in various leadership roles within the marketing and communications sectors. Currently serving as the Brand Marketing Manager at Releaf since March 2024, Mags also holds the position of Marketing Director at Heroic Hearts Project UK, supporting veterans in accessing psychedelic therapy on a voluntary basis. As Co-Owner of The Psychedelic Society, Mags focuses on curating and hosting events related to psychedelic science and mental health. Previous roles include Head of Projects & Communications and Head of Project Twenty21 at Drug Science, where Mags contributed to evidence-gathering for medical cannabis. Mags has held multiple positions in notable advertising agencies such as AMV BBDO and McCann Manchester, managing high-profile accounts and branding projects. Mags holds a First Class Honours degree in Music from The University of Manchester and an Electronic Music Production & Composition Diploma.
This person is not in any teams
Releaf
1 followers
Releaf, founded in 2022, is a healthcare company dedicated to transforming patient access to Cannabis Based Products for Medical use (CBPMs) in the UK. Despite the legalisation of medical cannabis in 2019, its uptake has been limited. An estimated 1.8 million people in the UK rely on illicit street cannabis for medical purposes, while over 20 million adults could benefit from CBPMs but are unaware of their options. Currently, only around 30,000 people in the UK have an active CBPM prescription. The primary obstacles to broader adoption are the complexity of the prescribing process and a lack of awareness among medical professionals and potential patients. Releaf has made significant investments in developing a HealthTech platform to streamline access to CBPMs for patients with various health conditions. The platform was launched in February 2024, eliminating previous barriers and bringing about fundamental changes in the UK's CBPM sector. Our Leadership Team has a proven track record in navigating complex, regulated markets. Through substantial investments in time, money, and expertise, we have developed Releaf's HealthTech operating platform. This platform simplifies the intricate and makes the opaque transparent, ensuring a seamless, single online session for patients to access CBPMs for their relevant conditions. Press enquiries: Press@releaf.co.uk